Adjuvant Trastuzumab Benefit in Patients Diagnosed With Triple-Positive Breast Cancer.
Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor.
Anne F
AF
Schott
D001943:Breast Neoplasms; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab
D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab